Abstract
Sleep is a complex, highly regulated process essential for human health and wellbeing. Increasingly, sleep–wake disturbance has been implicated in the pathogenesis of chronic liver disease, particularly the development and progression of non-alcoholic fatty liver disease and alcohol-related liver disease. Patients with cirrhosis also have a high burden of sleep abnormalities with substantial implications for their quality of life and physical health. This Review summarises the epidemiology and pathophysiology of sleep–wake disturbance in liver disease and discusses the multiple converging pathways leading to abnormal sleeping patterns in patients with cirrhosis. This includes contributions from altered melatonin metabolism, neuromuscular complications, and aberrant thermoregulation. In turn, a vicious cycle is established whereby disrupted sleep can further contribute to liver disease progression. We also begin to unravel the complex, interlinking relationship between sleep–wake disturbance and hepatic encephalopathy, discussing both overlapping and distinct mechanisms and clinical features. Finally, we summarise the current and future therapeutic approaches aiming to improve sleep quality in patients with cirrhosis.
Original language | English |
---|---|
Pages (from-to) | 850-863 |
Number of pages | 14 |
Journal | Lancet Gastroenterology & Hepatology |
Volume | 6 |
Issue number | 10 |
Early online date | 15 Jul 2021 |
DOIs | |
Publication status | Published - Oct 2021 |
Bibliographical note
Acknowledgments:JWT has received funding from the Medical Research Council (reference MR/P011462/1). TM receives funding from a Wellcome Trust Clinical Research Training Fellowship (reference 102176/B/13/Z). No funders were involved in the writing of the manuscript or the decision to submit for publication.